| 1 |
Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease |
|
| | Itsuro Kazama | | | Inflammation Research. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Good practice statements for antithrombotic therapy in the management of
COVID
-19: Guidance from the
SSC
of the
ISTH
|
|
| | Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, Mark Goldin, Beverley J. Hunt, Taiwo R. Kotila, Renato D. Lopes, Sam Schulman | | | Journal of Thrombosis and Haemostasis. 2022; | | | [Pubmed] [Google Scholar] [DOI] | |
|
